Clinical Trial

Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a double-blind randomized controlled trial evaluating the effect of perioperative dual bronchodilator therapy on post-operative pulmonary function and health-related quality of life (QoL) in mild-to-moderate less symptomatic COPD patients undergoing lung cancer surgery. Investigators hypothesized that dual bronchodilator, as compared with placebo, would prevent reduction of pulmonary function after surgical resection and improve postoperative health related QoL.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-08-28; most recent amendment 2026-06-23.
Status change: Recruiting → Active, Not Recruiting 2026-06-23
Status change: Not Yet Recruiting → Recruiting 2021-04-01
Trial Details
NCT Number NCT04536675
Lead Sponsor Samsung Medical Center
Conditions Chronic Obstructive Pulmonary Disease, Non Small Cell Lung Cancer
Enrollment 204 participants
Start Date 2021-04-01
Primary Completion 2026-04-03 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-26